| Home About BIT Members | Register | Brochure Events  Management Center | Contact Us  İ
 Information
  About WSA
  Organizers & SAB
  Who Should Attend
  Why attend
  Past Event Report
 Program
  Schedule
  Full Program
 Document
  Invitation Letter
  Download Booklet
  For your VISA
  Deadline
 Call for
  Speakers
  Posters
  Papers
  Media Partners
 Tech Tour
  Introduction of Kunming
  Tour in Yunnan
 Registration
  Registration Online
  Price
  Accommodation
 Seek Cooperation
  Project
  Foundation
  Resource Database
  Experts
 Sponsors
  Your Benefits
  Sponsorship Opportunities
  Sponsor Now!
 Contact Us
  Contact Us

Organization
----------------------------------
 
  Support Organization
Partners
Gold Sponsor

Full Scientific Program
Theme: Combating Severe Viral Infections
Time: July 20-22, 2008
Place: Empark Grand Hotel(EGH), Kunming,China
Tech Tour
Time: July 23-26, 2008
Place: Lijiang & Shangri-La, Yunan, China
The scientific program for the conference is under development by selecting hot topics for oral presentations and technological summary for posters. Poster sessions will be held through the whole summit.
 

July 19, 2008

Time

Lobby of Empark Grand Hotel Kunming

8:00-20:00
Registration
 
July 20-22, 2008
Opening Ceremony and Keynote Forum
(Time:
09:00-11:30 July 20, 2008, Sunday Place: International Hall, 3F)
08:15-08:30
Group Photo in front of the Hotel
09:00-09:30
Opening Ceremony
Keynote & Plenary Lectures
Host:
Dr. Shibo Jiang, Head, Laboratory of Viral Immunology, Lindsley F. Kimball Research Institute, New York Blood Center, USA
09:30-10:10
Title: HIV/AIDS Research: Perspectives from the Past and Prospects for the Future
Dr. Robert C. Gallo, Director, Institute of Human Virology University of Maryland, USA
10:10-10:50
Title: Infectious Agents in the Causation of Human Cancers
Dr. Harald zur Hausen, Professor Emeritus, German Cancer Research Institute, Germany
10:50-11:30
Title: HIV /AIDS in China-A Potential Epidemic?
Dr. Konglai Zhang, Professor, Chinese Academy of Medical Science and Peking Union Medical College, China
11:30-13:00
Luncheon


Track 1: Public Health and Basic Sciences for Emerging and Major Viral Infectious Diseases

Session 1: Global Plans and Multi-Lateral Cooperative for Responding to Emerging and Re-Emerging Viral Infectious Diseases
(Time:
13:30-17:45 July 20, 2008, Sunday Place: VIP Conference Room 1, 3F)
Session Chair:
Dr. Sanjib Bhattacharyya, Chief Molecular Scientist and Principal Investigator, Select Agent Program for Bioterrorism Preparedness & Response, City of Milwaukee Health Department,USA
Co-Chair:
Dr. A K Prasad, Chairman, Influenza Foundation of India, India
13:30-13:35
Session Introduction  
13:35-14:00
Title: Eradication of Helminthic Infections May be Essential for Successful Vaccination Against HIV in Most Developing Countries
Dr. Gadi Borkow, Chief Medical Scientist, Cupron Inc., USA
14:00-14:25
Title: Pandemic Preparedness: Community Approach Model for Strengthening National and Global Response Plan to Combat Viral Infections
Dr. Sanjib Bhattacharyya, Chief Molecular Scientist and Principal Investigator, Select Agent Program for Bioterrorism Preparedness & Response, City of Milwaukee Health Department,USA
14:25-14:50
Title: Risk Assessment of Emerging Flaviviruses: High Flavivirus Antibody Prevalence in Wild Ducks Captured in Hokkaido, Japan
Dr. Mika Saito, Instructor, Division of Molecular Virology and Oncology, Graduate School of Medicine, University of the Ryukyus, Japan
14:50-15:15
Title: HIV Vaccine Preparedness Studies in the Non-Organization for Economic Co-Operation and Development (Non-OECD) Countries
Dr. Shayesta Dhalla, Physician, Department of Health Care and Epidemiology, University of British Columbia, Canada
15:15-15:30
Tea Break
15:30-15:55
Title: Human Influenza Pandemic in Waiting
Dr. A K Prasad, Chairman, Influenza Foundation of India, India
15:55-16:20
Title: Collateral Effects of Antiviral Drugs - an Important Problem for the Medical Practice
Dr. Mihai Nechifor, President, Romanian Society for the Study of Chemotherapeutics, Romania
16:20-16:45
Title: New Emerging Viruses: Group-Specific Antivirals would be the Answer
Dr. Claude P. Muller, Director, Institute of Immunology, National Public Health Laboratory, Luxembourg
16:45-17:10
Title: What to Target to Control the HIV Infection in South Africa?
Dr. Banwari Meel, Professor and Head, Department of Forensic Medicine and Toxicology, Walter Sisulu University, South Africa
17:10-17:35
Title: Distribution Strategies of the Limited Amounts of Antiviral Medicine and Vaccines in a Context of Pandemic Influenza. Simulation Studies Using Global Epidemic Model (GEM)
Dr. Georgiy Bobashev, Senior Research Statistician, RTI International, USA
17:35-17:45
Discussion
Session 2: Etiology and Epidemiology of Viral Infections
(Time:
13:30-17:00 July 21, 2008, Monday Place: VIP Conference Room 1, 3F)
Session Chair: Dr. R. Palmer Beasley, Director, Center for International Training and Research (CITAR), University of Texas School of Public Health at Houston, USA
Co-Chair: Dr. Reinhard Kurth, Professor, Robert Koch Institute, Germany
13:30-13:35
Session Introduction
13:35-14:05
Keynote Speech:
Title: The Renaissance of Infectious Diseases as a Consequence of Human Behavior
Dr. Reinhard Kurth, Professor, President of the Robert Koch Institute, Germany
14:05-14:35
Title: Chronic Fatigue Syndrome Research in Latvia 2002-2007
Dr. Ludmila Viksna, Chief of Infectology Chair, Riga Stradins University, Latvia
14:35-15:05
Title: Discovery of and Mechanistic Insight into Activation by Dioxin-Type Xenobiotics of Cancer- Linked Common Human Viruses and HIV-1 Virus
Dr. Ilya B.Tsyrlov, Chief Scientific Officer, XENOTOX Inc.,USA
15:05-15:20

Tea Break

15:20-15:50
Title: Epidemiology and Clinical Outcomes of HBV Infection
Dr. Prapan Jutavijittum, Associate Professor, Department of Pathology, Faculty of Medicine, Chiang Mai University, Thailand
15:50-16:20
Title: Spectral Analysis of HIV Seropositivity among Migrant Workers Entering Kuwait
Dr. Saeed Akhtar, Associate Professor, Faculty of Medicine, Kuwait University, Kuwait
16:20-17:00

Discussion

Session 3: Epidemiology and Virology
(Time: 08:30-09:35 July 22, 2008, Tuesday Place: VIP Conference Room 1, 3F)
Session Chair:
Dr. Lu-Yu Hwang, Professor, Epidemiology / Disease Control, Director, Laboratory of Virology/ STDs Research, Center for Infections Diseases (CID), Associate Director, Center for International Training & Research (CITAR), University of Texas, School of Public Health at Houston , Texas, USA
08:30-08:35

Session Introduction

08:35-09:05

Title: Measles Control in Guangxi, China: High Risk County Selection and its Campaign Strategy
Dr. Jiatong Zhuo, Deputy Director, Guangxi CDC, China
09:05-09:35

Title: Epidemiology and Prevention of HIV, HBV and HCV Infection among Hard to Reach Drug Users: Experiences from the Inner City Neighborhoods of the United States
Dr. Lu-Yu Hwang, Professor, Epidemiology / Disease Control, Director, Laboratory of Virology/STDs Research, Center for Infections Diseases (CID), Associate Director, Center for International Training & Research (CITAR), University of Texas School of Public Health at Houston, Texas, USA
Session 4: Informatics, Biostatistics and Mathematical Modeling for Antiviral Researches
(Time: 09:40-11:00 July 22, 2008, Tuesday Place: VIP Conference Room 1, 3F)
Session Chair:
Dr. Paolo Carloni, Full Professor, International School for Advanced Studies (SISSA/ISAS), Italy
Co-Chair: Dr. Georgiy Bobashev, Senior Research Statistician, RTI International, USA
09:40-9:45

Session Introduction

09:45-10:10
Title: Clinical Characteristics and Treatments on Cytomegalovirus Retinitis Associated with AIDS in Shanghai
Dr. Ying Shi, Director, Shanghai Public Health Clinical Center Affiliated to Fudan University,China
10:10-10:35

Title: Macromolecular Aggregates Containing HIV-1 Proteins Investigated by Computational Methods
Dr. Paolo Carloni, Full Professor, International School for Advanced Studies (SISSA/ISAS), Italy
10:35-11:00

Title: Distribution Strategies of the Limited Amounts of Antiviral Medicine and Vaccines in a Context of Pandemic Influenza. Simulation Studies Using Global Epidemic Model (GEM)
Dr. Georgiy Bobashev, Senior Research Statistician, RTI International, USA

Track 2: Major Antiviral Drug Discovery and Development

Session 5: Targets of Respiratory Viruses Infection and the Corresponding Antiviral Therapeutics
(Time:
13:30-15:50 July 22, 2008, Tuesday Place: VIP Conference Room 1, 3F )
Session Chair: Dr. Yhu-Chering Huang,Chief ,Pediatric Research Center, Chang Gung Children's Hospital, Taiwan
13:30-13:35
Session Introduction
13:35-14:05
Title: Implementing a Community Based Tuberculosis Management Program in Namibia
Dr. Valerie Janet Ehlers, Professor, Department of Health Studies, University of South Africa, South Africa
14:05-14:35
Title: Inhibition of SARS Virus Entry by Medicinal Herbs
Dr. Toshio Hattori, Professor, Div Emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Japan
14:35-15:05

Title: Influenza-Associated Central Nervous System Dysfunction in Taiwanese Children and Young Adolescents: Clinical Characteristics and Outcomes with and without Exposure to Oseltamivir
Dr. Yhu-Chering Huang, Chief, Pediatric Research Center, Chang Gung Children's Hospital, Taiwan
15:05-15:35

Title: Infectivity of Elderly Humans by Avian Influenza Virus (AIV)
Dr. Julia Albright, Senior Technical Advisor, International Relief & Development, Inc., USA
15:35-15:50
Tea Break & Discussion
Session 6: Omics and System Biology for Viral Infectious Diseases
(Time:
13:30-16:05 July 20, 2008, Sunday Place: VIP Conference Room 3, 3F )
Session Chair: Dr. Xiaohua (Douglas) Zhang, Associate Director, Biometrics Research, Merck Research Laboratories, USA
Co-Chair:

Dr. Bing Sun, Co-Director, Institute Pasteur of Shanghai, Chinese Academy of Sciences, China

13:30-13:35
Session Introduction
13:35-14:00
Title: Human Coronavirus SNE Protein Regulates Virus Assembly and Release via Activation of Endogenous L-type Calcium Channel
Dr. Bing Sun, Co-Director, Institute Pasteur of Shanghai, Chinese Academy of Sciences, China
14:00-14:25
Title: Analytic Methods in Genome-Scale RNAi Research with Applications in Drug Discovery for Viral Infectious Diseases
Dr. Xiaohua (Douglas) Zhang, Associate Director, Biometrics Research, Merck Research Laboratories, USA
14:25-14:50

Title: Transcription Factor Egr-1 Enhances the Infection and Virulence of HSV-1
Dr. Ching Li, Professor, Department of Microbiology and Immunology, National Chiayi University, Taiwan
14:50-15:15
Title: Finding Signatures for Response to IFN Treatment in Chronic Hepatitis C Virus Patients with Genotype 1a, 1b, and 3a: a Multi Bioinformatics Approach
Dr. Mahmoud M. ElHefnawi, Researcher, Department of Medical Biotechnology, Division of Genetic Engineering and Biotechnology, National Research Centre, Egypt
15:15-15:40

Title: Using Genetic Approach to Identify Herpesvirus Pathogenic Genes
Dr. Hua Zhu, Associate Professor, UMDNJ-New Jersey Medical School, USA
15:40-16:05

Title: Functional Switch of Dendritic Cells during Chronic Hepatitis C Virus Infection
Dr. Li Zhao, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada
Workshop: Career Development-Research Opportunities for Young Scientists
(Time:
16:05-16:45 July 20, 2008, Sunday Place: VIP Conference Room 3, 3F )
16:05-16:45

Title: Career in Biostatistics
Dr. Misrak Gezmu, Mathematical Statistician, NIH, NIAID, DCR, BRB, USA
Session 7: Upstream Platform Technologies for Antiviral Drug Discovery
(Time:
08:30-12:00 July 21, 2008, Monday Place: VIP Conference Room 1, 3F)
Session Chair: Dr. Tetsuya Toyoda, Professor, Principal Investigator, Unit of Viral Genome Regulation, Institute Pasteur of Shanghai, Chinese Academy of Sciences, China
Co-Chair: Dr. Qianjun Li, Research Scientist, Drug Discovery, Southern Research Institute, USA
08:30-08:35
Session Introduction
08:35-09:05

Keynote Speech:
Title: Arbovirus and Relative Disease in Mainland China
Dr. Guodong Liang, Professor, Department of Viral Encephalitis and Arbovirus, Institute for Viral Disease Control and Prevention, China CDC, China
09:05-09:35
Title: Developing a Novel High-Throughput Screening Assay against Arboviruses
Dr. Qianjun Li, Research Scientist, Drug Discovery, Southern Research Institute, USA
09:35-10:05

Title: Elucidation of Host Factors Involved in Replication of Hepatitis C Virus
Dr. Kunitada Shimotohno, Professor, Research Institute, Chiba Institute of technology, Japan
10:05-10:20

Tea Break

10:20-10:50

Title: In Vitro Transcription System for Drug Screening and Evaluation of Polymerase Inhibitors.
Dr. Tetsuya Toyoda, Professor, Principal Investigator, Unit of Viral Genome Regulation Institute Pasteur of Shanghai, Chinese Academy of Sciences, China
10:50-11:20
Title: Efficient Functional Protein Selection Based on Ribosome Display Technology
Dr. Xiao-Ling Zhao, Associate Professor, Institute of Health and Enviramental Medicine, Academy of Military Medical Sceience, China
11:20-11:50

Title: New Druggable Targets, Novel Anti-Flu Agents
Dr. Richard Y.T. Kao, Director, Chemical Genetics Unit, Center of Infection and Immunology, Assistant Professor, Department of Microbiology, LKS Faculty of Medicine, the University of Hong Kong, China
11:5 -12:00
Discussion
Session 8: Frontier of Gene and Cell Therapy for Viral Infectious Diseases
(Time:
13:30-15:40 July 21, 2008, Monday Place: VIP Conference Room 3, 3F)
Session Chair:
Dr. Jiann-Ruey Hong, Assistant Professor, Institute of Biotechnology, National Cheng Kung University
Co-Chair: Dr. Xiaojian Yao, Assistant Professor, University of Manitoba, Canada
13:30-13:35
Session Introduction
13:35-14:00
Title: Overcoming HIV-1 Vif's Blockage and Inhibiting Viral Replication by an Apobec 3G Fusion Protein
Dr. Xiaojian Yao, Assistant Professor, University of Manitoba, Canada
14:00-14:25

Title: Protein-Based Strategies for Nucleic Acid Delivery: A Tale of Two TAT Chimeras
Dr. Vijaya Gopal, Assistant Director, Centre for Cellular and Molecular Biology, India
14:25-14:50
Title: Knockdown of Betanodavirus Viral Necrotic Genes with siRNA Approach
Dr. Jiann-Ruey Hong, Assistant Professor, Institute of Biotechnology, National Cheng Kung University
14:50-15:15

Title: Side ET Toxicomanie
Dr. Abdelmajid ZAHAF, President, ATLMST/SIDA-Tunisian Association for STD/AIDS, Tunisian Association for the Prevention of Drug-abuse, Tunis
15:15-15:40
Title: Effects of Nanomodified Antisense Oligodeoxynucleotides on HIV Viral Replication
Dr. Hsiao-Nan Hao, Assistant Professor, Wayne State University, School of Medicine, USA
Session 9: Structure Based Antiviral Drug Design and Synthesis
(Time:
08:30-11:30 July 22, 2008, Tuesday Place: VIP Conference Room 3, 3F)
Session Chair:
Dr. Hong Zhou, Professor & Director, Department of Microbiology and Electron Imaging Center for Nanomachines, UCLA, USA
08:30-08:35
Session Introduction
08:35-09:00

Title: Discovery of Inhibitors Targeting Wild Type and Mutant M2 Channels of Influenza A
Dr. Guo-Chun Zhou, Investigator, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, China
09:00-09:25

Title: Nucleocapsid Protein NP as a Target for Inhibition of Flu Virus Replication
Dr. Ming-Daw Tsai,Distinguished Research Fellow, Genomics Research Center, Acting Director, Institute of Biological Chemistry, Academia Sinica, Taiwan
09:25-09:50

Title: CryoEM Structural Studies of Tumor Herpesviruses and Potential for Structure-Guided Drug Target Identification
Dr. Hong Zhou, Professor& Director, Department of Microbiology and Electron Imaging Center for Nanomachines, UCLA, USA
09:50-10:15

Title: Novel HIV-1 Attachment Inhibitor(s) Derived From Peptides of the Leukocyte Surface Antigen CD38
Dr. Andrea Savarino, Researcher, Italian Institute of Health,Italy
10:15-10:30
Tea Break
10:30-10:55

Title: Design, Synthesis and Preliminary Activity Assay of Influenza Virus Neuraminidase Inhibitors
Dr. Wen-Fang Xu, Professor, Department of Medicinal Chemistry, Shandong University, China
10:55-11:20

Title: A Proposal of the Way to Develop Highly Active and Lowly Toxic Antiviral Modified Nucleosides
Dr. Hiroshi Ohrui, Professor, Yokohama College of Pharmacy, Japan
11:20-11:30
Discussion
Session 10: Drug Discovery and Development on Major Emerging/Re-emerging Viral Diseases
(Time:
13:30-17:20 July 22, 2008, Tuesday Place: VIP Conference Room 3, 3F )
Session Chair: Dr. Girish J. Kotwal, Professor, Kotwal Bioconsulting, USA
Co-Chair: Dr. Yanjie Sun, Research Scientist, Drug Discovery Division, Southern Research Institute, USA
13:30-13:35
Session Introduction
13:35-14:00

Title: Adenosine Kinase is the Primary Enzyme for the Antiviral Activity of 1--D- Ribofuranosyl-3-ethynyl-[1,2,4] Triazole (ETAR) against Hantavirus
Dr. Yanjie Sun, Research Scientist, Drug Discovery Division, Southern Research Institute, USA
14:00-14:25

Title: Enveloped Virus Neutralizing Compounds (EVNCs) as Versatile Antivirals against Enveloped Viruses
Dr. Girish J. Kotwal, Professor, Kotwal Bioconsulting, USA
14:25-14:50

Title: Anti-Herpetic Therapeutic: A New Approach to Treatment of Herpes Infection
Dr. Guna Feldmane, August Kirchenstein Institute of Microbiology and Virology, Riga Stradins University, Latvia
14:50-15:15
Title: Secretory Small Molecule from Non-Pathogenic Oral Bacteria Up-Regulates APOBEC3 and Inhibits HIV-1 Replication
Dr. Bindong Liu,  Assistant Professor, Meharry Medical College, Center for AIDS Health Disparities, USA
15:15-15:30
Tea Break
15:30-15:55

Title: New Agents for the Treatment of Viral Diseases: from Common Cold to Alphaviruses-Induced Arthitis
Dr. Caterina Maugeri, Researcher, Angelini Research Center,Italy
15:55-16:20

Title: Newly Synthesized Ketonucleoside Derivatives are Promising Inhibitors of RNA and DNA Viruses
Dr. Avrelija Cencic, Professor, University of Maribor, Faculty of Agriculture and Faculty of Medicine, Slovenia
16:20-16:45
Title: Antiviral Activity of Hexose Glycosides Complex
Dr. Mikhail Gomberg, Director for Science, Chief Researcher, Federal Institute for Blood Substitutes and Pharmaceuticals, Russia
16:45-17:10
Title: Artificially Composed Herbal Extract in Cure of Hepatitis
Dr. Pauli Virtanen, Laboratory Manager and Vice Director, Turku University, Finland
17:10-17:20
Discussion
Session 11: Drug Targets for HBV and the Corresponding Antiviral Therapeutics
(Time:
13:30-17:10 July 20, 2008, Sunday Place: No.1 Conference Room, 3F )
Session Chair:
Dr. Ilya B.Tsyrlov, Chief Scientific Officer, XENOTOX Inc. ,USA
Co-Chair: Dr. Hong Zhang, Project Manager, Beijing Enlinor Pharmaceutical Technology Co. Ltd., China
13:30-13:35
Session Introduction
13:35-14:15

Keynote Speech:
Title: The Hepatitis B Virus: from Cloning to Vaccine
Dr. Pierre Tiollais, Professor, Nuclear Organization and Ontogenesis Unit, INSERM U579, Institute Pasteur, France
14:15-14:45

Title: Hepatitis B Virus Replication Might be Upregulated by Human Body Burden Dioxin: Epidemiological Data and Therapeutic Approach
Dr. Ilya B.Tsyrlov, Chief Scientific Officer, XENOTOX Inc. , USA
14:45-15:15

Title: HBV in Subsahran Africa and SE-Asia: New Subtypes, Multiple Double/Triple Recombinations, A new Genotype and Several Puzzles
Dr. Claude P. Muller, Director, Institute of Immunology, National Public Health Laboratory, Luxembourg
15:15-15:30
Tea Break
15:30-16:00

Title: MIV-210, A Promising Candidate Drug for Treating Hepatitis B Virus Infection
Dr. Hong Zhang, Project Manager, Beijing Enlinor Pharmaceutical Technology Co. Ltd., China
16:00-16:30

Title: HBV Treatment: Actual Clinical Updates
Dr. Giorgio Barbarini, Chief, Outstanding Patients Department of Infectious and Tropical Diseases of Foundation IRCCS San Matteo University of Pavia, Italy
16:30-17:00
Title: Detection of HBV Lamivudine-Resistant Mutations and Genotypes by PCR-RFLP, Touch-Down Real-Time PCR and DHPLC Assay
Dr. Yanqin Lu, Associate Professor, Shandong Medicinal Biotechnology Centre, China
17:00-17:10

Discussion

Session 12: HCV Key Viral Proteins, Drug Targets and the Corresponding Antiviral Therapeutics (Part I)
(Time:
08:30-11:30 July 21, 2008, Monday Place: VIP Conference Room 3, 3F )
Session Chair:

Dr. Thomas I. Michalak, Professor of Molecular Virology and Medicine, Senior Canada Research Chair in Viral Hepatitis/Immunology, Molecular Virology and Hepatology Research, Faculty of Medicine, Memorial University, Canada

Co-Chair:

Dr. Hengli Tang, Assistant Professor, Florida State University, USA

08:30-08:35

Session Introduction

08:35-09:05

Keynote Speech:
Title: Novel Receptor and Small Molecule Inhibitors for HCV Entry
Dr. Flossie Wong-Staal, CSO, Executive Vice President Research, iTherX Pharmaceuticals, Inc., USA
09:05-09:35

Title: Small Interfering RNAs Targeting an Essential Cellular Cofactor of HCV Polymerase as A Potential Anti-HCV Therapy
Dr. Hengli Tang, Assistant Professor, Florida State University, USA
09:35-10:05

Title: Characterization of A Novel and Potent HCV Helicase Inhibitor
Dr. Zhuhui Huang, Project Leader, Hepatitis Research Program, Southern Research Institute, USA
10:05-10:20

Tea Break

10:20-10:50
Title: Occult Hepatitis C Virus and Hepatitis B Virus Infections: Identification, Clinical Consequences and Therapeutic Interventions
Dr. Thomas I. Michalak, Professor of Molecular Virology and Medicine, Senior Canada Research Chair in Viral Hepatitis/Immunology, Molecular Virology and Hepatology Research, Faculty of Medicine, Memorial University, Canada
10:50-11:20

Title: Treatment of Hepatitis C after Liver Transplantation
Dr. Sandeep Mukherjee, Associate Professor of Internal Medicine, Nebraska Medical Center, Section of Gastroenterology and Hepatology, USA
11:20-11:50

Title: Neutralizing the Hepatitis C Virus
Dr. Mats A. A. Persson, Karolinska Institutet, Stockholm, Sweden
Session 13: HCV Key Viral Proteins, Drug Targets and the Corresponding Antiviral Therapeutics (Part II)
(Time:
13:30-17:15 July 21, 2008, Monday Place: No.1 Conference Room, 3F)
Recent Clinical Trial Results with Host- and Specifically-Targeted Antiviral Therapies for HCV (STAT-C)
Vertex Co-organized and Sponsored Session

Session Chair:

Dr. Ann D Kwong, Head of Infectious Diseases, Vertex Pharmaceuticals, Inc., Cambridge, MA USA
Co-Chair:
Dr. Dongping Xu, Director and Professor, Viral Hepatitis Research Laboratory, PLA Institute of Infectious Diseases, Beijing, China
13:30-13:35
Session Introduction
13:35-14:00


Ann D Kwong instead of Lindsay McNair

Keynote Speech:
Title: How the New Therapeutic Regimens in Development May Change the Standard of Care for HCV
Dr. Lindsay McNair, Senior Medical Director, Vertex Pharmaceuticals, Inc., Cambridge, MA USA
14:00-14:25

Title: HCV Polymerase Inhibitors-1: Update of Non-Nucleoside Inhibitor Clinical Trial Results
Dr. Louise Proulx, Vice President, Product Development, ViroChem Pharma, Montreal, Canada
14:25-14:50
Title: Potency, Selectivity, and Molecular Mechanism of Balapiravir: A Nucleoside Inhibitor of HCV Polymerase
Dr. Han Ma, Research Scientist, Viral Diseases Biology Areas, Roche Palo Alto,LL, USA
14:50-15:15
Review Talk: Distribution of Genotypes and Impact of HCV Disease in Asia
Dr. Dongping Xu, Director and Professor, Viral Hepatitis Research Laboratory, PLA Institute of Infectious Diseases, Beijing, China
15:15-15:30
Tea Break
15:30-15:55

Review talk: The Genetic and Structural Basis of HCV Resistance to STAT-C Inhibitors
Dr. Chao Lin, Research Fellow, Infectious Diseases, Vertex Pharmaceuticals, Inc., Boston, MA, USA
15:55-16:20

Title: Host-Targeted Inhibitors: Update of HCV Clinical Trial Results
Dr. Raf Crabbe, Medical Director, Debiopharm, SA, Lausanne, Switzerland
16:20-16:45

Title: HCV Protease Inhibitors-1: Update of Macrocyclic Peptidomimetic Clinical Trial Results
Dr. Tse-I Lin, Principle Scientist, HCV Tibotec BVBA, Mechelen, Belgium
16:45-17:10
Title: HCV Protease Inhibitors-2: Update of Linear Peptidomimetic Inhibitor Clinical Trial Results
Dr. Tara Kieffer, Group Leader, Infectious Diseases Vertex Pharmaceuticals, Inc., Boston, MA, USA
17:10-17:15
Wrap up: Closing Remarks
Dr. Dongping Xu, Director and Professor, Viral Hepatitis Research Laboratory, PLA Institute of Infectious Diseases, Beijing, China
Session 14: Antibodies and Vaccines as Antiviral Therapeutics
(Time:
13:30-16:30 July 22, 2008, Tuesday Place: No.1 Conference Room, 3F )

Session Chair:

Dr. Thomas R. Kreil, Director, Global Pathogen Safety, Baxter BioScience, Austria
Co-Chair:
Dr. Vidadi Yusibov, Fraunhofer USA Center for Molecular Biotechnology, USA
13:30-13:35
Session Introduction
13:35-14:05
Keynote Speech:
Title: Antibodies as Antivirals
Dr. Thomas R. Kreil, Director, Global Pathogen Safety, Baxter BioScience, Austria
14:05-14:35

Title: Evaluation of Microgen's Intranasal Live Attenuated Influenza Vaccine H5N2 (Pre-Clinical and Clinical Study)
Dr. Alla Lobastova, Senior Manager of R&D Department, Microgen State Scientific Industrial Company, Moscow, Russia
14:35-15:05

Title: Therapeutic Vaccination against Lethal Poxvirus Infection
Dr. Hubertus Hochrein, Manager,Research Immunology, Bavarian Nordic GmbH, Germany
15:10-15:35
Title: Signal Transduction Pathways Specifically Triggered by Activated Epstein-Barr Virus receptor (EBV/C3dR, gp140, CR2, CD21) in Human B Lymphocytes: New Targets to Control Infection by EBV
Dr. Raymond Frade, INSERM U.354 Centre INSERM, Hospital Saint-Antoine, Paris , France
15:05-15:20

Tea Break

15:20-15:50

Title: An Influenza N1 Neuraminidase-Specific Monoclonal Antibody Protects Animal Against Live Challenge with Homologous H5N1 Virus
Dr. Vidadi Yusibov, Executive Director, Fraunhofer USA Center for Molecular Biotechnology, USA
15:50-16:20
Title: Experimental B and T Cell Stimulating Recombinant Vaccines for Flaviviruses Guided by Human Immune Responses
Dr. Vijaya Satchidanandam, Professor, Department of Microbiology and Cell Biology, Indian Institute of Science, India

Track 3: Sensitive and Accurate Diagnostic Tests

Session 15: Sensitive and Accurate Diagnostic Tests
(Time:
08:30-12:00 July 21, 2008, Monday Place: No.1 Conference Room, 3F)

Session Chair:

Dr. Miroslav Sip, Head of the Department of Laboratory Methods and Medical Technology, Faculty of Health and Social Studies, University of South Bohemia, Czech Republic
Co-Chair:
Dr. Christiane Honisch, Group Leader Molecular Applications, SEQUENOM, Inc., USA
08:30-8:35

Session Introduction

08:35-9:00
Keynote Speech:
Title: Molecular Diagnostics Using Mass Spectrometry of Nucleic Acids
Dr. Charles Cantor, Founder, Chief Scientific Officer, SEQUENOM, Inc., USA
09:00-9:25

Title: Perspectives of Molecular-Recognition-Based Methods in Reliable Virus Diagnostics
Dr. Miroslav Sip, Head of the Department of Laboratory Methods and Medical Technology, Faculty of Health and Social Studies, University of South Bohemia, Czech Republic
09:25-09:50

Title: Simultaneous Detection and Definitive Identification of Viral and Bacterial Respiratory Pathogens Using Resequencing Microarrays
Dr. Zuwei Qian, Associate Director, Affymetrix, USA
09:50-10:15
Title: Chronic Enterovirus Infections: the Post-Polio Syndrome and Insulin-Dependent Diabetes
Dr. Antonio Toniolo, Professor and Director, Laboratory of Medical Microbiology, University of Insubria Medical School,Italy
10:15-10:30

Tea Break

10:30-10:55
Title: Speedy Antibody Generation against Enterovirus 71
Dr. Le Sun, CEO & President, AbMax Biotechnology, Inc., China
10:55-11:20
Title: Applying Mass Spectrometry and Molecular Identification to Infectious Diseases
Dr. Christiane Honisch, Group Leader, Molecular Applications, SEQUENOM, Inc., USA
11:20-11:55
Title: Novel Mechanisms for HIV Dementia and Biomarker Discovery Using Proteomics
Dr. Loyda M. Melendez, Professor, Department of Microbiology and Medical Zoology, RCMI, Proteomics Core Director, University of Puerto Rico, Puerto Rico
11:55-12:00
Discussion

Track 4: Commemrate Symposium of HIV/AIDS

Session 16: Basic Science and Technology of HIV/SIV
(Time:
13:30-15:30 July 20, 2008, Sunday Place: No.2 Conference Room, 3F)

Session Chair:

Dr. Doris B. Tse, Director, Division of Infectious Disease and Immunology,Department of Medicine, New York University School of Medicine, USA
Co-Chair:
Dr. Tian Jin, Principal Investigator, Chemotaxis Signal Section, Laboratory of Immunogenetics, National Institute of Allergy Infectious Diseases, NIH, USA
13:30-13:35
Session Introduction
13:35-14:00
Title: Biomarkers to Assess HIV Infection and Treatment
Dr. Doris B. Tse, Director, Division of Infectious Disease and Immunology,Department of Medicine, New York University School of Medicine, USA
14:00-14:25
Title: Infection by Primate Lentiviruses and Innate Immunity
Dr. Anne Marie Aubertin, Director, Institute of Virology, University Louis Pasteur, France
14:25-14:50
Title: Visualization of CD4 and CCR5 Dynamics during the Formation of HIV Entry Complex Using Live Cell FRET and the Single-Molecule Imaging
Dr. Tian Jin, Principal Investigator, Chemotaxis Signal Section, Laboratory of Immunogenetics, National Institute of Allergy Infectious Diseases, NIH, USA
14:50-15:15
Title: The Use of MOIST HEAT as Defenitive Treatment for AIDS and Other Diseases
Dr. Mohamed Samir Abdel-Rheem, Consultant of Surgery, Damanhour National Medical Institute, Damanhour, Egypt
15:15-15:30
Tea Break & Discussion
Session 17: Anti-AIDS Microbicides & Prevention of AIDS
(Time:
08:30-12:00 July 21, 2008, Monday Place: No.2 Conference Room, 3F)

Session Chair:

Dr. Shibo Jiang, Head, Laboratory of Viral Immunology, Lindsley F. Kimball Research Institute, New York Blood Center, USA
Co-Chair:
Dr. Gadi Borkow, Chief Medical Scientist, Cupron Inc. ,USA
08:30-08:35
Session Introduction
08:35-09:05

Title: Toward a Carbohydrate-Based HIV Vaccine
Dr. Lai-Xi Wang, Associate Professor of Chemistry & Biochemistry, Institute of Human Virology and Department of Biochemistry & Molecular Biology, University of Maryland School of Medicine, USA
09:05-09:35
Title: Innovations in Analytical Chemistry to Promote the HIV Prevention and Treatment Agenda
Dr. Naser Rezk, Co-director, University of North Carolina at Chapel Hill, USA
09:35-10:05
Title: Deactivation of HIV -1 in Suspension by Copper-Oxide Containing Filters
Dr. Gadi Borkow, Chief Medical Scientist, Cupron Inc. ,USA
10:05-10:20
Tea Break
10:20-10:50
Title: Development of CAP Combination Microbicide
Dr. Shibo Jiang, Head, Laboratory of Viral Immunology, Lindsley F. Kimball Research Institute, New York Blood Center, USA
10:50-11:20
Title: MIV-160, a Vaginal Microbicide Candidate Exhibits a Superior Anti-HIV Activity
Dr. Hong Zhang, Chief Scientific Officer, Beijing Mefuvir Medicinal Science Co. Ltd., China
11:20-11:50
Title: Highly Sulphated Oligosaccharides as Novel Microbicides Against HIV-1 and Genital Herpes Simplex
Dr. Joanna Said, Department of Infectious Diseases, Clinical Virology, Gothenburg University, Sweden
11:50-12:00
Discussion
Session 18: Anti-HIV Chemotherapeutics R & D
(Time:
15:40-16:30 July 21, 2008, Monday Place: VIP Conference Room 3, 3F)

Session Chair:

Dr. Sulie Chang, Director, Institute of NeuroImmune Pharmacology, College of Arts and Science, Seton Hall University, USA
15:40-16:05
Title: Peltophorum Africanum (Fabaceae) and its Compounds, A Potent Arsenal Against HIV-AIDS
Dr. Edmund S Bizimenyera, Professor, Department of Agriculture, Animal Health and Human Ecology, University of South Africa, South Africa
16:05-16:30
Title: Automated Docking Analysis Provides New Insights on Protease Inhibitor Selection for Antiretroviral Therapy in HIV-1 Infection
Dr. Carlos Familia, Invited Auxiliar Professor, Egas Moniz Health Science Institute, Portugal
Session 19: NeuroAIDS
(Time:
08:30-11:30 July 22, 2008, Tuesday Place: No.1 Conference Room, 3F )

Session Chair:

Dr. Huangui (Hank) Xiong, Associate Professor, University of Nebraska Medical Center, USA
Co-Chair: Dr. Wenzhe Ho, Director, The Children's Hospital of Philadelphia, USA
08:30-8:35
Session Introduction
08:35-9:05
Keynote Speech:
Title: NeuroAIDS and Drugs of Abuse
Dr. Sulie Chang, Director, Institute of NeuroImmune Pharmacology, College of Arts and Science, Seton Hall University, USA
09:05-9:35
Title: HIV and Host Interplay: A Tale of Two Partners?
Dr. Shilpa Buch, Associate Professor, University of Kansas Medical Center, USA
09:35-10:05
Title: Opioids, Innate Immunity and HIV/HCV
Dr. Wenzhe Ho, Director of Retrovirology Laboratory, The Children's Hospital of Philadelphia, Professor of University of Pennsylvania School of Medicine, USA
10:05-10:20
Tea Break
10:20-10:50
Title: Drug Abuse, Opportunistic Infection and NeuroAIDS
Dr. Sabita Roy, Professor and Director, Division of Infection, Inflammation and Vascular Biology, University of Minnesota, USA
10:50-11:20
Title: Macrophages, Neuronal K Channels and HIV-Associated Dementia
Dr. Huangui (Hank) Xiong, Associate Professor, University of Nebraska Medical Center, USA
11:20-12:00
Discussion
©2008 All right reserved for BIT Life Sciences
  Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629